Mark G. Currie, Chief Scientific Officer at IRONWOOD PHARMACEUTICALS INC (IRWD), sold 275,000 shares at $13.29 ($3.6M) on 2019-03-07, disclosed to the SEC on 2019-03-08.
Seasonal sale ($3.6M) by Chief Scientific Officer — this insider has traded IRWD in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.29 | 225,500 | $3.0M | 82.2% |
| 2 | $13.15 | 49,500 | $651K | 17.8% |
| Total | $13.26 avg | 275,000 | $3.6M | 100% |
| Filing → |
| IRWD | SELL | 2021-06-16 | $546K | — | Filing → |
| CYCN | SELL | 2020-12-30 | $121K | — | Filing → |
| IRWD | SELL | 2020-01-24 | $755K | — | Filing → |